The department store operator reported mixed results for its fiscal third quarter, with an earnings beat but a slight revenue ...

Will Nvidia's AI dominance drive another earnings surprise? With the stock up 200% this year, all eyes are on Nov. 20 ...

Q3 2024 Earnings Call Transcript November 13, 2024 Dole plc misses on earnings expectations. Reported EPS is $0.19 EPS, ...

Q3 2024 Earnings Call Transcript November 13, 2024 Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS ...

Airbnb’s key business metrics showed decent growth rates amid a challenging macro backdrop. Read why we anticipate headwinds ...

Palantir's earnings continue to highlight the company's profitability. Read why PLTR stock valuation may seem excessive for ...

Paymentus Holdings, Inc. (NYSE:PAY) shares traded higher premarket on Wednesday after the company reported third-quarter ...

Here’s a rundown of the EV maker’s report. Q3 Revenue: $891,000, versus estimates of $2.11 million Q3 Adjusted EPS: Loss of ...

Reports Q3 revenue $140M, consensus $139.49M. Dr. Yoav Zeif, Stratasys (SSYS)’ CEO, stated, “Our decisive actions to realign our ...

Reports Q3 revenue $153.1M, consensus $153.77M. Q4 enrollments at Rasmussen, which are known at the end of Q3 increased 3.5% vs. last year, the ...

Repligen posted solid growth and beat Wall Street's sales and adjusted earnings estimates.

British drugmaker AstraZeneca increased its full-year sales outlook on booming demand for its cancer and rare-disease drugs, and said it plans to invest $3.5 billion in its U.S. business by the end of ...